Yuanyuan Zhang | Tissue Regeneration | Best Researcher Award

Dr. Yuanyuan Zhang | Tissue Regeneration | Best Researcher Award

Associate Dean at Wake Forest School of Medicine, United States

Dr. Yuanyuan Zhang is an accomplished Associate Professor at Wake Forest University School of Medicine, currently based at the Institute for Regenerative Medicine in Winston-Salem, North Carolina. With a career spanning over three decades, Dr. Zhang has made significant contributions to the fields of regenerative medicine, urology, and tissue engineering. Her expertise lies at the intersection of cell biology and urological reconstruction, with a focus on developing bioengineered tissues for clinical application. As a physician-scientist, her translational research bridges basic science and therapeutic innovation, earning her a reputation for advancing the frontiers of regenerative urology. She has served in numerous academic, clinical, and research roles across China, Switzerland, New Zealand, and the United States, contributing globally to the advancement of urologic tissue engineering and regenerative medicine.

Profile

Scopus

Education

Dr. Zhang began her educational journey at Jiangxi Medical College (Nanchang University), where she earned her M.D. equivalent in 1982 and her M.S. in Biological Sciences in 1989. Her master’s research, under the mentorship of Dr. Shi-ping Peng, investigated the protective effects of ginsenosides on renal ischemia, establishing a foundation in nephrology and cellular protection. She later pursued a Ph.D. in Biomedicine at the University of Lausanne in Switzerland, where she focused on co-culturing bladder urothelial and smooth muscle cells on small intestinal submucosa for potential tissue engineering applications. This early work laid the groundwork for her future contributions to organ regeneration and bioengineering.

Experience

Dr. Zhang’s clinical training includes multiple residency and fellowship programs in China, including the 2nd and 1st affiliated hospitals of Jiangxi Medical College and advanced fellowships in endourology in Guangzhou and Shanghai. She furthered her expertise in renal transplantation and nephrology during her fellowship at the University of Otago in New Zealand. Between 1997 and 2000, she completed postdoctoral training at the University of Oklahoma Health Science Center, a critical period in which she refined her research in pediatric urology and regenerative techniques. These cumulative experiences enriched her clinical and academic perspectives, supporting her transition to high-impact research and teaching roles in the U.S.

Research

Dr. Zhang’s research interests center around urological tissue engineering, regenerative medicine, stem cell applications, and biomaterials. Her pioneering investigations into the reconstruction of the bladder and urethra using cell-seeded scaffolds have contributed to the evolution of functional tissue substitutes. Additionally, she explores stem cell differentiation, extracellular matrix bioactivity, and translational strategies for clinical urologic repair. Her laboratory work is aimed at solving complex challenges in tissue replacement and organ repair, with a particular emphasis on pediatric and reconstructive urology.

Awards

Dr. Zhang has received numerous accolades and has been recognized through various international and national research initiatives. Her contributions have made her a frequent reviewer for the NIH NIDDK since 2009, and she has evaluated proposals for prestigious agencies including the Sick Kids Foundation of Canada and The Netherlands Organisation for Health Research and Development. These appointments reflect her standing in the global scientific community and her commitment to advancing medical research through peer evaluation and mentorship.

Publications

Among her impactful publications, several stand out for their scientific merit and citations. In Tissue Engineering Part A (2005), her work titled “Tissue-engineered bladder: A novel approach for reconstruction” has been cited over 600 times, demonstrating the field’s reliance on her innovation. Another key paper, “Urothelial cell growth on small intestinal submucosa” published in Biomaterials (2003), received over 400 citations. Her 2007 publication in Stem Cells on “Stem cell-seeded scaffolds for urethral regeneration” continues to be cited extensively (300+ citations). Additional notable works include articles in Nature Clinical Practice Urology (2008), Journal of Urology (2006), and Regenerative Medicine (2010), each reflecting her interdisciplinary approach. Her research has also informed clinical trial design and inspired further investigation into bladder regeneration and functional scaffold development.

Conclusion

In conclusion, Dr. Yuanyuan Zhang exemplifies excellence in academic medicine, translational research, and international collaboration. With a strong foundation in clinical urology and a visionary approach to tissue engineering, she continues to advance regenerative therapies that hold the potential to transform patient care. Her publications, global training background, and consistent contributions to peer-reviewed grant evaluation underscore her as a leader in the field. As an educator, researcher, and clinician, Dr. Zhang’s work resonates across disciplines and borders, making her a highly deserving nominee for recognition in regenerative medicine and biomedical innovation.

Dr. Yihai Liu | Translational Medicine | Best Researcher Award

Dr. Yihai Liu | Translational Medicine | Best Researcher Award

Dr. Yihai Liu | Nanjing Drum Tower Hospital | China

Dr. Yihai Liu is a dedicated biomedical researcher specializing in cardiovascular diseases, immunology, and bioinformatics. Based in Nanjing, he has made significant contributions to understanding cardiac inflammation, fibrosis, and myocardial infarction. His research focuses on molecular mechanisms, gene expression, and therapeutic targets for heart diseases. With numerous publications in high-impact journals, Dr. Liu is also an editor and reviewer for esteemed scientific journals. His expertise spans translational medicine, oxidative stress, and immune response regulation, making him a key figure in advancing biomedical research. Passionate about innovation, he continues to explore novel therapeutic strategies for cardiovascular health. 🧬❤️

Professional Profile:

Google Scholar

Suitability for the Best Researcher Award

Dr. Yihai Liu is a highly accomplished biomedical researcher with expertise in cardiovascular diseases, immunology, and bioinformatics. His work has significantly advanced the understanding of cardiac inflammation, fibrosis, and myocardial infarction by elucidating molecular mechanisms and identifying novel therapeutic targets.

Education & Experience 🎓💼

  • 🎓 B.Sc. – [University not specified]
  • 🎓 Ph.D. – [University not specified]
  • 🏫 Lecturer (Year unspecified), Nanjing
  • 🔬 Postdoctoral Researcher (Year unspecified), Nanjing
  • 👨‍🏫 Associate Professor/Professor (Year unspecified), Nanjing

Professional Development 📚🔍

Dr. Yihai Liu is actively involved in academic publishing, peer reviewing, and editorial work. He serves as an editorial board member for Traditional Medical Research and BMC Cardiovascular Disease and as a guest editor for the Journal of Visualized Experiments. Additionally, he reviews manuscripts for top-tier scientific journals, including BMJ Open, European Journal of Public Health, and Frontiers in Endocrinology. His contributions extend to evaluating research in nanobiotechnology, environmental sciences, and public health. With a strong commitment to scientific integrity and innovation, Dr. Liu plays a pivotal role in advancing knowledge across multiple biomedical disciplines. 🏅📖

Research Focus🧪🧬

Dr. Yihai Liu’s research spans cardiovascular diseases, immune system regulation, and bioinformatics. His studies explore cardiac inflammation, fibrosis, and myocardial infarction, with a focus on molecular pathways, oxidative stress, and genetic regulation. His work integrates cellular mechanisms, computational biology, and translational medicine, aiming to identify novel therapeutic targets. He has contributed to understanding effector cells, immune mediators, and gene expression in heart diseases. His research also extends to drug-induced cardiac injury, abdominal aortic aneurysms, and zebrafish heart development. Through multidisciplinary approaches, he strives to develop personalized treatments and precision medicine strategies for cardiovascular health. ❤️🩺

Awards & Honors 🏆🎖️

Editorial Board Member – Traditional Medical Research & BMC Cardiovascular Disease 📚
Guest Editor – Journal of Visualized Experiments 🏅
Reviewer for Prestigious Journals – BMJ Open, Journal of Nanobiotechnology, Frontiers in Endocrinology, British Journal of Nutrition, etc. ✍️
Published in High-Impact Journals – J Cell Physiol, J Int Med Res, Biochem Biophys Res Commun, etc. 📖
Key Contributor to Bioinformatics Research – Identified therapeutic targets in hepatocellular carcinoma 🧬

Publication Top Notes:

📌 miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury – Z Wei, S Qiao, J Zhao, Y Liu, Q Li, Z Wei, Q Dai, L Kang, B Xu  🔗 Cited by: 194
🍎 Association between composite dietary antioxidant index and hypertension: insights from NHANES – M Wu, J Si, Y Liu, L Kang, B Xu  📈 Cited by: 89
🦠 Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: A secondary analysis based on a single-center, retrospective study – J Ni, H Wang, Y Li, Y Shu, Y Liu  ⚕️ Cited by: 80
💊 Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis – D Mu, J Li, Y Qi, X Sun, Y Liu, S Shen, Y Li, B Xu, B Zhang  🔬 Cited by: 46
❤️ Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity – Y Liu, J Xu, M Wu, B Xu, L Kang 💉 Cited by: 45